Serotonin and noradrenaline reuptake inhibitors (SNRI) vs placebo
Withdrawals due to adverse events · patients with fibromyalgia
Serotonin noradrenaline reuptake inhibitors may leads to higher tolerability (withdrawal due to adverse events) compared with placebo (low certainty).
1 finding from 1 review
- Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia 2018 · Cochrane Headline outcomes onlyRD 0.07 [0.04, 0.1]15 studies · 7029 participantsLow